Market Cap ₹49 Cr.
Stock P/E 24.7
P/B 1.8
Current Price ₹9.3
Book Value ₹ 5
Face Value 1
52W High ₹21.9
Dividend Yield 0%
52W Low ₹ 7.7
Baba Arts Limited is a media and entertainment company based in India, primarily engaged in film production and distribution. Established with the vision of contributing to the Indian film industry, the company focuses on creating and distributing quality content across various genres. Baba Arts is known for its innovative storytelling and has been involved in several successful film projects. The company not only produces films but also plays a significant role in the marketing and distribution of its productions, enhancing their reach in both domestic and international markets. With a commitment to excellence, Baba Arts Limited aims to explore new avenues in filmmaking and is continuously looking to collaborate with talented professionals in the industry. Through its diverse portfolio, the company seeks to entertain and engage audiences while contributing to the growth of the Indian cinema landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 1 | 1 | 1 | 5 | 5 | 1 | 1 | 1 | 1 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 1 | 1 | 1 | 1 | 5 | 6 | 1 | 1 | 1 | 1 |
Total Expenditure | 0 | 0 | 1 | 1 | 5 | 3 | 1 | 1 | 1 | 1 |
Operating Profit | 0 | 0 | 1 | 1 | 0 | 2 | -0 | 1 | 0 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 2 | -0 | 1 | 0 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 1 | -0 | 0 | 0 | 0 |
Profit After Tax | 0 | 0 | 0 | 0 | 0 | 2 | -0 | 0 | 0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | 2 | -0 | 0 | 0 | 0 |
Adjusted Earnings Per Share | 0 | 0.1 | 0.1 | 0.1 | 0 | 0.3 | -0 | 0.1 | 0.1 | 0.1 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 5 | 86 | 8 | 1 | 1 | 1 | 0 | 13 | 18 | 3 | 11 | 4 |
Other Income | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 0 |
Total Income | 5 | 86 | 9 | 2 | 3 | 2 | 1 | 16 | 19 | 4 | 12 | 4 |
Total Expenditure | 5 | 89 | 9 | 2 | 2 | 1 | 1 | 12 | 15 | 2 | 10 | 4 |
Operating Profit | -0 | -2 | 0 | 1 | 1 | 2 | 1 | 3 | 4 | 1 | 3 | 1 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -1 | -3 | 0 | 0 | 1 | 2 | 0 | 3 | 4 | 1 | 3 | 1 |
Provision for Tax | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
Profit After Tax | -1 | -3 | 0 | 0 | 1 | 1 | 0 | 3 | 3 | 1 | 2 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -1 | -3 | 0 | 0 | 1 | 1 | 0 | 3 | 3 | 1 | 2 | 0 |
Adjusted Earnings Per Share | -0 | -0.3 | 0 | 0 | 0.2 | 0.3 | 0.1 | 0.5 | 0.6 | 0.2 | 0.4 | 0.3 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 267% | -5% | 62% | 8% |
Operating Profit CAGR | 200% | 0% | 8% | 0% |
PAT CAGR | 100% | -13% | 15% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -35% | -21% | 26% | 7% |
ROE Average | 8% | 9% | 9% | 4% |
ROCE Average | 11% | 12% | 12% | 6% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 34 | 31 | 31 | 23 | 18 | 16 | 17 | 19 | 22 | 23 | 25 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 |
Total Current Liabilities | 26 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 2 |
Total Liabilities | 60 | 32 | 32 | 23 | 19 | 16 | 17 | 20 | 24 | 24 | 28 |
Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Other Non-Current Assets | 1 | 3 | 3 | 2 | 2 | 1 | 0 | 1 | 2 | 4 | 2 |
Total Current Assets | 57 | 27 | 27 | 19 | 15 | 14 | 15 | 17 | 20 | 19 | 24 |
Total Assets | 60 | 32 | 32 | 23 | 19 | 16 | 17 | 20 | 24 | 24 | 28 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 5 | 0 | 13 | 18 | 11 | 1 | 1 | 1 | 0 | 4 | 2 |
Cash Flow from Operating Activities | -6 | 14 | 5 | -1 | 0 | 1 | -0 | -2 | 0 | -2 | 5 |
Cash Flow from Investing Activities | 0 | 0 | 1 | 1 | -5 | 2 | 0 | 1 | 3 | -0 | -6 |
Cash Flow from Financing Activities | 1 | -2 | -0 | -8 | -5 | -4 | -0 | -0 | -0 | -0 | -0 |
Net Cash Inflow / Outflow | -4 | 13 | 6 | -8 | -10 | -0 | -0 | -0 | 3 | -2 | -1 |
Closing Cash & Cash Equivalent | 0 | 13 | 19 | 11 | 1 | 1 | 1 | 0 | 4 | 2 | 1 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -0.05 | -0.25 | 0 | 0.01 | 0.17 | 0.27 | 0.09 | 0.53 | 0.57 | 0.19 | 0.38 |
CEPS(Rs) | -0.02 | -0.23 | 0.02 | 0.03 | 0.19 | 0.28 | 0.09 | 0.54 | 0.58 | 0.21 | 0.39 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 3.31 | 3.04 | 3.04 | 2.93 | 3.05 | 3.07 | 3.16 | 3.69 | 4.26 | 4.45 | 4.83 |
Core EBITDA Margin(%) | -9.41 | -3.16 | -12.98 | -140.45 | -7.47 | 14.86 | -342.38 | 7.71 | 18.16 | 12.99 | 15.33 |
EBIT Margin(%) | -9.24 | -3.02 | 1.02 | 18.06 | 67.99 | 180.9 | 268.77 | 24.21 | 22.85 | 48.11 | 23.78 |
Pre Tax Margin(%) | -10.62 | -3.06 | 0.97 | 16.94 | 67.23 | 180.49 | 256.89 | 24.16 | 22.81 | 47.8 | 23.76 |
PAT Margin (%) | -10.37 | -3.06 | 0.56 | 17.27 | 73.05 | 159.61 | 253.93 | 21.05 | 16.51 | 36.67 | 17.22 |
Cash Profit Margin (%) | -4.76 | -2.82 | 2.38 | 37.12 | 80.17 | 165.85 | 276.18 | 21.39 | 16.84 | 38.78 | 17.7 |
ROA(%) | -1.05 | -5.66 | 0.14 | 0.41 | 4.89 | 7.88 | 2.72 | 15.39 | 13.75 | 4.26 | 7.55 |
ROE(%) | -1.47 | -8.02 | 0.14 | 0.41 | 5.02 | 8.08 | 2.78 | 15.6 | 14.26 | 4.47 | 8.1 |
ROCE(%) | -1.29 | -7.77 | 0.25 | 0.43 | 4.68 | 9.16 | 2.94 | 17.94 | 19.73 | 5.86 | 11.19 |
Receivable days | 455.48 | 14.04 | 102.02 | 376.19 | 79.38 | 128.04 | 58.75 | 2.03 | 23.06 | 158.81 | 14.91 |
Inventory Days | 2638.25 | 131.31 | 297.55 | 824.88 | 0 | 0 | 23.75 | 36.76 | 54.27 | 533.63 | 164.03 |
Payable days | -22.13 | 16.6 | 26.95 | 252.96 | 213 | 0 | 0 | 8.02 | 13.13 | 294.66 | 16.32 |
PER(x) | 0 | 0 | 487.23 | 240.51 | 14.79 | 13.95 | 32.85 | 17.42 | 35.03 | 67.95 | 33.32 |
Price/Book(x) | 1.84 | 1.63 | 0.68 | 1.19 | 0.83 | 1.2 | 0.9 | 2.52 | 4.66 | 2.97 | 2.59 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 13.03 | 0.44 | 0.32 | 25.22 | 5.05 | 16.62 | 49.2 | 3.26 | 5.3 | 20.61 | 4.21 |
EV/Core EBITDA(x) | -358.24 | -15.95 | 11.12 | 29.62 | 6.72 | 8.88 | 16.91 | 13.26 | 22.87 | 41.04 | 17.35 |
Net Sales Growth(%) | -41.95 | 1656.77 | -90.87 | -91.74 | 117.58 | -38.15 | -79.52 | 7353.71 | 35.26 | -84.53 | 311.19 |
EBIT Growth(%) | -134.68 | -474.1 | 103.08 | 46.42 | 719.34 | 64.54 | -69.57 | 571.36 | 27.65 | -67.42 | 103.25 |
PAT Growth(%) | -160.25 | -417.99 | 101.67 | 155.44 | 820.14 | 35.14 | -67.41 | 517.77 | 6.13 | -65.65 | 93.15 |
EPS Growth(%) | -160.23 | -417.99 | 101.67 | 240.58 | 1086.61 | 54.49 | -67.41 | 517.75 | 6.12 | -65.64 | 93.12 |
Debt/Equity(x) | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 2.18 | 29.45 | 55.84 | 44.73 | 26.63 | 34.18 | 33.37 | 77.67 | 18.2 | 33.33 | 9.83 |
Quick Ratio(x) | 0.2 | 18.29 | 50.93 | 43.47 | 26.63 | 34.18 | 33.34 | 65.63 | 15.81 | 23.84 | 7.87 |
Interest Cover(x) | -6.69 | -82.22 | 21.28 | 16.18 | 89.07 | 441.75 | 22.64 | 546.58 | 697.71 | 154.15 | 1048.38 |
Total Debt/Mcap(x) | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 74.68 | 74.68 | 74.68 | 74.68 | 74.68 | 74.68 | 74.68 | 74.68 | 74.68 | 74.68 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 25.32 | 25.32 | 25.32 | 25.32 | 25.32 | 25.32 | 25.32 | 25.32 | 25.32 | 25.32 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 | 5.25 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About